EUVIMEDEUVIMED entdecken
Crossref

Intralesional Methotrexate: A Cost-Effective, High-Efficacy Alternative to Surgery for Cutaneous Squamous Cell Carcinoma

Ashley Lou Rensted, Alexander Hall, Joseph Giancola, Neel Patel

Cutis · 01.01.2026 · 1 (117)

DOI: 10.12788/cutis.1338 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cutis, erschienen am 01.01.2026. Verfasst von Ashley Lou Rensted und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ashley Lou Rensted is from Creighton University School of Medicine, Omaha, Nebraska. Alexander Hall is from the Department of Research and Compliance…. Hauptthemen laut MEDLINE: Methotrexate, Skin Neoplasms, Carcinoma, Squamous Cell, Antimetabolites, Antineoplastic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Squamous cell carcinoma (SCC) is the second most common type of skin cancer and often is treated surgically. Not all patients are surgical candidates, and sometimes the cost of Mohs micrographic surgery or wide local excision is a barrier for patients. In this study, we explored the use of intralesional methotrexate (IL-MTX) as a treatment for SCC. Our results demonstrate that treatment with IL-MTX could be an excellent option for patients who cannot be treated surgically. However, more research is needed to characterize which lesions are the best candidates for IL-MTX therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateSkin NeoplasmsCarcinoma, Squamous CellAntimetabolites, AntineoplasticHumansInjections, IntralesionalCutaneous Squamous Cell CarcinomaCost-Benefit AnalysisMohs SurgeryTreatment OutcomeMale

Substanzen

MethotrexateAntimetabolites, Antineoplastic

Autor:innen und Institutionen

  • Ashley Lou Rensted is from Creighton University School of Medicine, Omaha, Nebraska. Alexander Hall is from the Department of Research and Compliance, Creighton University School of Medicine, Omaha, Nebraska. Drs. Gianc…

Zitieren

APA

Rensted, A. L., Hall, A., Giancola, J., & Patel, N. (2026). Intralesional Methotrexate: A Cost-Effective, High-Efficacy Alternative to Surgery for Cutaneous Squamous Cell Carcinoma. Cutis, 1(117). https://doi.org/10.12788/cutis.1338

Vancouver

Rensted AL, Hall A, Giancola J, Patel N. Intralesional Methotrexate: A Cost-Effective, High-Efficacy Alternative to Surgery for Cutaneous Squamous Cell Carcinoma. Cutis. 2026;1(117). doi:10.12788/cutis.1338

BibTeX
@article{Rensted2026,
  author = {Rensted, Ashley Lou and Hall, Alexander and Giancola, Joseph and Patel, Neel},
  title = {Intralesional Methotrexate: A Cost-Effective, High-Efficacy Alternative to Surgery for Cutaneous Squamous Cell Carcinoma},
  journal = {Cutis},
  year = {2026},
  volume = {1},
  number = {117},
  doi = {10.12788/cutis.1338}
}
Kostenlos starten →